Unknown

Dataset Information

0

Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Features of Pediatric Respiratory Syncytial Virus Infection in Japan.


ABSTRACT:

Background

Mitigation measures implemented during the coronavirus disease 2019 (COVID-19) pandemic remarkably reduced the incidence of infectious diseases among children. However, a re-emergence of respiratory syncytial virus (RSV) infection was observed in 2021 in Japan. We compared the clinical characteristics of hospitalized patients with RSV infection before and during COVID-19.

Methods

We retrospectively enrolled children aged <6 years who were hospitalized with RSV infection in 18 hospitals and compared their clinical characteristics before (January 2019 to April 2020, 1675 patients) and during COVID-19 (September 2020 to December 2021, 1297 patients).

Results

The mean age of patients with RSV infection was significantly higher during COVID-19 than before (17.4 vs 13.7 months, P < .001). Compared with before COVID-19, a 2.6-fold increase in RSV cases in the 2-5 years age group was observed from sentinel surveillance during COVID-19, whereas a 1.2-fold increase was noted in the same age group among hospitalized patients. On average for all patients, consolidation shadows obtained on radiography were less frequently observed (26.1 vs 29.6%, P = .04), and reduced respiratory assistance (42.2% vs 48.7%, P < .001) and hospitalization stay (5.7 vs 6.0 days, P < .001) was required in patients with RSV infection during COVID-19.

Conclusions

Coronavirus disease 2019 and social activity restriction caused epidemiological changes in pediatric RSV infections, and a majority of patients with RSV infection aged ≥2 years did not develop severe symptoms requiring hospitalization. The RSV symptoms during the COVID-19 outbreak were equivalent to or milder than in the previous seasons.

SUBMITTER: Ozeki S 

PROVIDER: S-EPMC9620303 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of the Coronavirus Disease 2019 Pandemic on the Clinical Features of Pediatric Respiratory Syncytial Virus Infection in Japan.

Ozeki Shoko S   Kawada Jun-Ichi JI   Yamashita Daiki D   Yasufuku Chika C   Akano Takuya T   Kato Masahiro M   Suzuki Konomi K   Tano Chihiro C   Matsumoto Kazuki K   Mizutani Shu-Hei SH   Mori Ayumi A   Nishio Nobuhiro N   Kidokoro Hiroyuki H   Yasui Yoshihiro Y   Takahashi Yoshiyuki Y   Sato Yoshiaki Y  

Open forum infectious diseases 20221022 11


<h4>Background</h4>Mitigation measures implemented during the coronavirus disease 2019 (COVID-19) pandemic remarkably reduced the incidence of infectious diseases among children. However, a re-emergence of respiratory syncytial virus (RSV) infection was observed in 2021 in Japan. We compared the clinical characteristics of hospitalized patients with RSV infection before and during COVID-19.<h4>Methods</h4>We retrospectively enrolled children aged <6 years who were hospitalized with RSV infection  ...[more]

Similar Datasets

| S-EPMC9129219 | biostudies-literature
| S-EPMC8807230 | biostudies-literature
| S-EPMC10748361 | biostudies-literature
| S-EPMC10041497 | biostudies-literature
| S-EPMC7340134 | biostudies-literature
| S-EPMC8920880 | biostudies-literature
| S-EPMC8544984 | biostudies-literature
| S-EPMC8060823 | biostudies-literature